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INTRODUCTION 
Cancer is a disease which has been recognized since ancient times 
and which in every generation has killed many victims of all ages and 
of all stations in life. The disease has been fought against from 
generation to generation with whatever ideas and tools available at 
that time. Today, although cures for many diseases have been found, 
cancer is still under inve�tigation and more efforts are demanded to 
·oveTcome ·the disease. In cancer chemoth�rapy, it is hoped that drugs 
can be found which will have a selectively toxic effect on neoplastic 
cells. 
5-Fluorouracil was synthesized in 1957 by Duochinky, Pleven, and 
Heidelberger and has been intensively studied. The agent produces a 
significant incidence of objective responses in patients suffering 
from advanced solid tumors, particularly in breast and gastrointestinal 
cancers, and prolongs the life of patients with breast carcinomas, but 
at the expense of some bone marrow and gastrointestinal.toxicities. 
The toxicities result from the lack of real selectivity against cancer 
cells by this drug. 
The cytotoxic action of nitrogen mustard compounds was first 
applied to the treatment of malignant neoplasms in the 1940s following 
the observation of Gilman and Philips that these agents caused 
regression of certain experimental tumors, Hodgkins' disease, and 
lymphosarcoma. A nitrogen mustard derivative, cyclophosphamide, 
was synthesized by Arnold, Bourseaus and Brock in 1958. The 
2 
selective activity of cyclophosphamide toward cancer- cells.in com­
parison to nitrogen mustards per� is of interest and induced the 
research objective of synthesizing a similar derivative of 5-fluouracil 
to decrease the side effects of 5-fiuorouracil. 
RESEARCH OBJECTIVE 
It is believed that a significant percentage of human cancer can 
be cured or at least controlled by chemotherapy, but the number of 
3 
'cures' of neoplastic disease in man that have been attained by the 
use of drugs is still small. The major stumbling block to successful 
cancer chemotherapy, besides the emergence of natural or·aquired 
drug-resistance, is a lack.of real selectivity against tumor cells. 
This results from the close metabolic resemblance of cancer cells to 
the normal cells from which they are derived. Because of the close 
similarity of normal cells and neoplastic cells, it is often necessary 
to use drugs close to their toxic dosage range in order to cause 
anticancer effects. The effectiveness of most anticancer agents, 
excluding the hormones, is probably related to their ability to inter­
fere with cell division and hence the toxicity associated with their 
use is usually encountered in the parts of the body where rapid cell 
proliferation takes place, such as in the bone marrow and in the 
gastrointestinal tract. Early signs of·bone marrow toxicity are 
leukopenia and thrombocytopenia. In addition to bone marrow and gas­
trointestinal disturbances, the most frequently observed side reactions 
are nausea and vomiting which probably result from central nervous 
system disturbances (1) . Other toxic symptoms encountered with a 
number of drugs are alopecia, anorexia, hepatoxicity, and thrombo­
phlebitis (2) ._ If a certain compound has a wide spectrum of toxicity 
to cells, the anticancer utility of such a compound will be very 
narrow and the therapeutic index poor. Becaus·e of this.· a: great 
4 
amount of effort has been expended in the search for compounds that are 
�electively toxic to malignant tissue. This search has met with some 
success, but the compound that will destroy only malignant tissue with 
little or no effect on normal cells has not, as yet, been found or 
synthesized. 
The discovery that mustard gas (bis-chloroethyl sulfide) resulted 
in a drastic reduction in �hiteblood cell count led to research 
·relative to aliphatic nitrogen mustards.�- Nitrogen mustards, as 
exempµfied by mechlorethamine (I), readily cyclize under physiolog­
ical conditions to the relatively stable ethylene im.inium ion (ll) then 
react with available nucleophilic centers resulting in an alkylated 
(denatured) substrate (III) (Fig. 1) (2). 
,CHiCH2Cl 
H3C-N 'CHiCH2Cl 
I 
RAH 
H�,/CH2 
,N.@ 
HJC 'cH�HiCl 
G 
Cl 
II 
�C;H2CH2AR 
Hf-N, 
CH2cH2Cl 
III 
+ HCl 
Fig. 1 Reaction between mechlorethamine and nucleophilic 
compound (RAH). 
When mechlorethamine was incubated with RNA or DNA, the major site of 
alkylation was shown to be the ?-nitrogen of guanine (IV) (Fig. 2) (J). 
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The alkylated form of the guanine moiety results in the deletion of the 
purine from the llJA structure with the formation of labile 'apurinic 
acid' (VI), and thus inhibition of DNA formation and protein synthesis 
(4). Mechlorethamine is more active (5) and has been more widely used 
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Fig. 2 Reaction between guanine and ethylene·iminium ion 
* ethylene iminium ion 
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in the treatment of cancer than an,y of its congeners. The beneficial 
results of mechlorethamine in Hodgkins ' disease and less predictably, 
in other lymphomas have been extensively confirmed. Palliative results 
also have been observed in chronic leukemias, polycythem:i.a vera, and 
carcinomas of the bronchus, ovary, breast, and nas opharynx ( 6) .• The 
i 
compound, however, cannot be referred to as .be�ng selectively toxic 
because of the fact that the ef�ective dosage of this agent is often 
limited by bone marrow toxicity, severe nausea, and vomiting. For 
producing more selectively toxic nitrogen mustards, several modified 
forms of nitrogen mustard have been synthesized and clinically investi­
gated, e.g. , l,6-bis(2-chloroethylamino)-1,6-dideoxy-D-mannitol 
(degranol, VII), 3-(p- bis{2-chloroethyl)amino phenyl)-L-alanine 
{melphalan, VIII), and 2- bis(2-chloroethyl)amino tetrahydro-2H-l,3, 
2-oxazaphosphorine-2-oxide (cyclophosphamide, IX). 
CH2NHCH2CH2Cl 
HOyH 
HOyH 
HCOH 
HyOH 
CH2NHCH2CH2Cl 
VII 
(0 
p -
I \\ 
N 0 
I 
VIII 
/ 
CH
2
CH2Cl 
N 
\ CH2CH2Cl 
IX 
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The development of cyclophosphamide resulted in one of· the more 
successful applications· of latentation ( 2) • Although the long-term 
_cyclophosphamide treatment has the side effects of leukopenia, thrombo­
penia and atrophy of epidermis (7), the greater specificity of cyclo­
phosphamide was studied and proved in comparison with other nitrogen 
mustards (mechlorethamine, normechlorethamine A (XI). etc.) (8). Due 
to_deactivation by the cyclophosphamide_ moiety, the compound is not 
toxic to tumor cells in .cu.lture-even · at high concentration (9), but, 
·if .it is .incubated with liver homogenate;p;ior to cytotoxicity eval-
uation, it is highly toxic (10). These facts indicate that the 
chemically inert structure may be cleaved by cellular phosphatases 
and phosphamidases (11). These enzymes do not occur in circulating 
plasma and cancerous cells contain greater amounts of phosphamidases 
(12) and phosphatases (13) than do normal cells. From this reasoning, 
some selectivity in toxicity could be assumed and apparently has been 
exhibited (6). Cyclophosphamide is presumed to be activated according 
to the following reactions (Fig. 3). The primary cleavage between the 
phosphorus and the ring nitrogen results.in the formation of the very 
stable internal salt (X). Under physiological conditions, hydrolysis 
at the nitrogen-phosphorus bond of the salt may occur so that the 
toxic normechlorethamine (XI) is liberated (2). Some dispute has been 
made that metabolism of cyclophosphamide does not seem to liberate 
either normechlorethamine or any other alkylating·agent (6). 
In order for cellular growth to take place, biosynthesis of DNA 
is essential. If this synthesis is interfered with, cellular growth 
0 u 
I 
---+ �2
N(CH2) 3-o-P-(
OH)2 + HN(C
H2CH2Cl)2 
XI 
Fig. 3 Activation of cyclophosphamide 
is impaired. An important basic component of the DNA helix is thymine 
8 
(5-methyluracil), linked as the deo,cyribonucleotide to other deoxyribo­
nucleotides in the helical structure. Since uracil is first incor­
porated into 2 1 -deoJCYUridine-5 1 -phosphate and this is methylated via 
the thymidylate synthetase system to give the thymine analogu� 
derivative· (Fig. 4) (14). a stable group in the 5-position on the 
uracil molecule would block this methylation. The compound 5-fluorour­
acil (XII) has proved this to be true. 
5-Fluorouracil is a potent cytotoxic agent because it is bio-isosteric 
with uracil and masquerades as uracil up to a biosynthetic point. 
5-Fluorouracil undergoes all the degradative and anabolic reactions 
or uracil with the important exception that the presence of the fluoro 
group prevents methylation of the 5-carbon of 5-fluoro-2 1-deoJCYUridine 
5'monophosphat� (FUdRMP) to form thymidylic acid and inhibits thymi­
dylate synthetase, an enzyme concerned with the methylation o� deo:xy-
9 
uridylic acid to fonn thymidylic acid (Fig._4) (14). 5-Fluorouracil 
has had extensive trial against.cancer in man. Clinical.responses have 
been reported in a variety.of cancers including those of the large 
·bowel, breast, stomach, ovary, thyroid, 
.
pancreas, cervix, pharynx 
and ur�nary bladder (15). Because or the lack of selective toxicity, 
tumor regression usually is obtained at the expense of some degree of 
toxicity which may be severe. Toxicologic effects are observed in the 
more rapidly proliferating tissues: the bone marrow, the gastroin­
testinal tract and sometimes, the skin, conjunctiva and vaginal and 
other mucosal tissues. Severe toxicity is associated with extensive 
-ulceration and hemorrhage of the gastrointestinal tract and aplasia 
of the marrow (14) . 
It would seem promising to incorporate onto the molecule of 
5-fluorouracil a large, hydrolyzeable group that would interfere with 
the bio-isosterism (masquerading as uracil) and yet could be removed 
(hydrolyzed) at the desired site of action. This should result in 
a compound selectively toxic for malignant tissue if the cleavage 
took place within the malignant cells• 
Considering the discussion of cyclophosphamide, the synthesis 
of a similar derivative of 5-fiuorouracil (XIIT) would be desirable. 
0 
H- N �H(F) 
.,_( ___ _,. J u J }. o�N 
H. 
Uracil 
( 5-Fluorouracil) 
OH H 
2 1Deoxyuridylic acid 
5'monophosphate 
(5-Fluoro-2•;..a.eo:xy-
uridine 5'monophos­
phate, FUdRMP) 
FUdRMP 
0 
H-N�H(F) 
0-l N :_j 
HOCH2 
H 
OH OH 
Uridine 
(5-Fluorouridine) 
Uridylic acid 
5'monophosphate 
(5-Fluorouridine 
5'monophosphate) 
Thymidylic acid 
5 'monophosphate 
Fig. 4 Synthesis of thymidylic acid 5 'monophosphate and 
action mechanism of 5-fluorouracil 
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This compound.would hopefully undergo cleavage undeP-the-infiuence 
of malignant cellular enzymes thus liberating the bio-:.isosteric, toxic 
5-fiuorouracil (Fig. 5). 
Enzymes 
xrn 
Fig. 5 Activation of the proposed derivative of 5-fluorouracil 
In order to determine the feasibility of synthesizing this 5-nuorour­
�cil derivative. 5-fiuorouracil was to be synthesized and subjected to 
phosphorylation reactions (Fig. 6). Although it is recognized that 
the activities of uracil and 5-fluorouracil are somewhat different, 
uracil was used as a test compound because it is relatively inexpen­
sive and readily synthesized compared to 5-fiuorouracil. The synthesis 
of uracil (Fig. 7) and the schemes for phosphorylation of uracil are 
. outlined (Fig. 8 and Fig. 9) . 
Cl 
N�� 
F 
I � < 
Ci� N" 
0 
POCl3 
(18) 
(19) 2 MO-�-OR I 
OR 
0 
II 
0-P-OR 
R I 
RO-P-0--t 
• 
OR 
XIV 
F 
.F KO, I 
__ ___,., ,C::COiEt 
H 
S-Et 
I. 0 
HiN-C=NH2
X, NaOMe 
. G) 
OH OH 
12 
. (16) 
NY
F 
HCl. H20 �
F 
11 
.... , ----"""( 1-7)�- r, 
OH� N EtS" N 
'j 
II 
(20) 2 K2co3
, 2 Cl-P-OEt 
I 
OEt 
0 
II 
0 -P-OEt 
6 F 0 � II EtO-P-0 
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Fig. 6 Schemes for phosphorylation of 5-fluorouracil 
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Fig. 7 Synthesi's of uracil 
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fig. 8 Scheme I for phosphorylation of uracil 
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. OH 
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Fig. 9 Scheme II for phosphorylation of uracil 
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DISCUSSION 
Uracil was synthesized .in a yield of 51 percent by the method 
of Davidso� et al. (21). Malic acid (XVI) in fuming sulfuric acid 
gave formylacetic acid (XVIII). Fifteen percent fuming sulfuric acid 
was recommended; no product was obtained if more concentrated (3�) 
fuming sulfuric acid was used and a poor yield (2o%) of the product 
was obtained if less con�entrated (J.�) fuming sulfuric acid was 
used. 
Pyrimidine may be considered as a resonance hybrid of XXX, XXXI, 
XXXII, IXnII {Fig. 10). Being located at the 1- and 3-positions, 
16 
the nitrogen atoms in pyrimidine cooperate in their electron directive 
effects with resulting reinforcement. Thus, it is expected and 
XXX XXXI ·XXXII XXXIII 
Fig. 10 Some important resonance structures of the pyrimidine 
ring 
indeed pyrimidine does possess properties similar to those of pyridine, 
but markedly different from benzene (29). The 2-, 4-, and 6-positions 
of pyrimidine, because of the powerful electron withdrawing effect of 
17 
the neighboring nitrogen atoms, are electron deficient. Halogen atoms 
at these positions, like those in alkyl halides, are easily substituted 
by nucleophilic agents (30). Since 2,4-dihalo pyrimidine possesses 
activity towards substitution reactions similar to alkyl halides, 
attempted reaction of 2,4-dichloropyrimidine with the silver salt of 
diethyl phosphate was applied in this research (Fig. 8). Alkyl iodides 
are popularly used in these rea�tions because the carbon�iodide bond 
is less stable and thus, the iodides have higher reactivity than the 
other halides (Fig. 11) (31). 2, 4-DichloroPYrimidine (llX) was chosen 
Iodides Bromides > Chlorides > Fluorides > 
( Increasing rate of reaction 
Fig. 11 Reactivity of alkyl halides 
as the reactant in the first synthetic attempts since it is easily 
synthesized from uracil. The dichloropyrimidine was synthesized from 
uracil by the procedure of Whittaker (Fig. 12) (16). N 1 N-Dimethyl 
HO 
OH 
N� 
J(N J + 
II 
Cl-P-Cl 
I 
Cl 
Cl 
N� 
> I 
Cl )l N .,,-
+ HP0
3 
+ HCl 
·Fig. 12 Reaction between uracil and phosphoryl oxychloride 
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aniline was added as a proton scavenger thus allowing a faster, more 
complete reaction. When an electron withdrawing group, e.g., fluoro, 
is present at the 5-position of uracil, the conversion of hydroxy 
groups with phosphoryl chloride is also successful. In this case, for 
effective reaction N, N-diethyl aniline is used (32). 
Silver diethyl phosphate (XX) was synt�esized from triethyl 
phosphate using the procedure of Drushel and Felty et al� (23). The 
only modification was, instead of triethyl phosphate being decomposed 
�y concentrated barium hydroxide solution, a mixture of triethyl phos­
phate and barium hydroxide in water was refluxed for one and one-half 
hours (27). In order to avoid photo instability of the silver com­
pounds, reactions involving these compounds were performed in the dark. 
Silver diethyl phosphate is not soluble in most organic solvents, very 
soluble in water and soluble in hot dioxane. Since the silver salt is 
very unstable in hot, commercial grade dioxane, purified dioxane was 
heated to about 60° for recrystalization of the salt. 
The difference of electron distribution in different positions 
of pyrimidine is indicated (Fig. 13) (33). Electron density at the 
2-position is more depleted by the inductive effects of the ring 
nitrogen atoms than at the 4-position; therefore, in mono-nucleophilic 
substitution of 2.4-dichloropyrimidine, the chloro group at the 
2-position would be replaced preferencially (34). The reaction of 
2,4-dichloropyrimidine and silver diethyl phosphate was run 
according to the procedure of Wolform et al. (19). Benzene, in which 
the silver salt is apparently insoluble, was used as the solvent. The 
+·. 0$4-
. - .o,41 N� +. 007 
t .ot♦6� NJ 
Fig. 13 Electron distribution of pyrimidine 
molar amounts of the re�ctants were such that disubstitution was 
-expected _(Fig. 8). but no product, either mono- or di-substituted 
"(In), was obtained. A reaction in purified dioxane which dissolves 
both of the reactants was also run. but the reaction was hindered by 
19 
the instability of the silver salt in hot dioxane. In order to increase, 
the possibility of interaction between the reactants, the pyrimidine 
and the silv�r salt were heated at 135° and also 155° without any 
solvent,· but no product was obtained. 
Reaction between alkyl halides and metallic (dialkyl) phosphates 
tak�s place at the oxygen atom of the phosphoryl group since the bond 
of the phosphoryl group is polar, hence �he oxygen atom carries an 
appreciable negative charge and can interact with an electrophilic 
center (Fig. 14) (35) .  Increasing the basicity of the phosphate 
(Fig. 15) would increase the negativity of the o�gen atom and might 
increase the reaction rate of the nucleophillc substitution (Fig. 8). 
Silver phosphate was synthesized following the procedure of Sneed 
et al. (24). To avoid 2, 4-dichloropyrimidine being hydrolized to 
uracil_ in the presence of water, the silver phosphate was dried to 
constant weight and commercial duodecahydrated sodium phosphate was 
dried at 105° for 12 hours to the least hydrated form. The dried 
inorganic phosphates and 2,4-dichloropyrimidine were heated according 
to the method of Wolform et ·al. (19) with some modifications: the 
reaction times were lengthened and the reactions were run in an 
atmosphere of nitrogen. 
�-
(i) .. e C?i ,. 
Ag :o -P - OR 
·J, 
OR 
Fig. 14 Mechanism of reaction between alkyl halide and silver 
dialkyl phosphate 
The reaction was run in the recommended solvent, benzene, and also 
at 120° without any solvent. All of the attempts were unsuccessful. 
0 
II 
Na0-P-ONa > 
I 
ONa 
0 
II 
AgO-P-OAg 
I 
OAg 
0 
II > AgO-P-OEt 
. J 
OEt 
t--- Increasing basicity 
Fig. 15 Basicity of phosphates 
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The reason that increasing the basicity of the phosphate did not 
increase the nucleophilic replacement might be due to the insolubility 
of the inorganic phosphates in benzene and also to decreased reactivity 
21 
of 2, 4-dichloropyrimidine in comparison with alkyl chlorides. Brown 
suggests (32) that the chloro groups in 2, 4-dichloropyrimidine have 
activities similar to those in aliphatic compounds, but more nearly to 
that of the chloro group in chloro-2, 4-dinitrobenzene. 
An attempt was made to synthesize 2,4-diiodopyrimidine because 
of expected increased reactivity of the iodo over the chloro analogue 
(Fig. 8). Sodium iodide in acetone will react with alky1 chlorides to 
give alkyl iodides (36). This reaction is useful since alkyl iodides 
cannot always be prepared by methods used for alkyl chlorides and 
bromides. The ability of the iodide ion to displace the other halo­
gens is due in part to the fact that sodium iodide is soluble in 
acetone while sodium. chloride is not. The insolubility of sodium 
chloride in acetone helps favor the formation of the alkyl iodide (J6) . 
In an attempt to synthesize diiodopyrimidine (XXII) , two methods were 
followed: the procedure of Rosenkranz et al. (28) with acetone as 
the solvent and the procedure of Kingdon and Wright (25) with 2-
butanone as the solvent. 2-Butanone has a higher boiling point and 
thus, higher reaction temperature can be-obtained. After refluxing, 
only trace amounts of precipitate (sodium chloride?) were noticed 
and the products from both methods had similar melting points (60-62°) 
as 2,4-dichloropyrimidine (61-62°) indicating that the chloro groups 
at the 2- and 4-positions of pyrimidine were not replaced by iodide. 
In dialkyl phosphorochloridate, the phosphorus-oxygen double 
bond is polar (35), the phosphorus being positive and electrophilic 
toward nucleophiles. This results in Sn2 replacement (Fig. 16) (37). 
0 0 X RO 
0@ II II/ I o 
R'O M + RO-P-X � RO-P --+ R'O-P� 
,, , I 
@0 
MX 
OR R'O OR RO 
Fig. 16 Reaction between metal alkoxide and dialkyl phosphoro­
chloridate 
With this reaction, the insecticidal agent, O, O-diethyl, 0-(2, 4-di­
.methyl-6-pyrimidyi) phosphate (XXXVI) was synthesized by Geigy (Fig. 
17) (29). An attempt was made to synthesize o, 'o, o,o-tetraethyl, O, 
- . 
,0-pyrimidine-2, 4-yl diphosphate (XXI) following the method of Geigy 
(Fig. 8) . 
XXXIV XXXV 
O CH 
Cl-�-oEt· _J 
OEt N5 0 
) h .,, II 
H CA N 0-P-OEt 3 oEt 
XXXVI. 
Fig. 17 Synthesis of O, O-diethyl, 0-(2,4-dimethyl-6-pyrimidyl) 
phosphate 
Uracil is an acid with pKa values or·9.J8 and 12 (10) and since the 
hydro:xylic proton at the 4-position is more ionizeable than the 
hydroxylic proton at the 2-position (38), the mono-potassium salt 
would be formed at the 4-position (XXIII). Because of this, the 
22 
expected product would be 0, 0-diethyl, 0-(2-hydro)cy'-4-pyrimidyl) phos­
phate (XXV) from reaction between diethyl phosphorochloridate (XXIV) 
and the potassium salt. Since the diethyl phosphate group at the 
4-position would theoretically lower the pKa of the remaining 2-
hydroxy group, 0, 0-diethyl, 0-(2-hydroxy-4-pyrimidyl) phosphate.would 
23 
be capable of forming a potassium salt with potassium carbonate at the 
2-position (XXVI) . Reaction of·the potassium salt with diethyl phos­
phorochloridate, again, by·nucleophilic substitution, would give 0, 0 
O, O�tetraethyl, O, O-pyrimidine-2,4-yl diphosphate (XXI). In the first 
step, uracil and potassium carbonate were refluxed for three hours in 
benzene and water was removed azeotropically. Only a trace amount of 
water was collected. No product was obtained in this experiment. The 
differences in properties between 2, 4-dimethyl-6-hydroxy-pyrimidine 
(XXXIV) and uracil were studied: 
a. 2, 4-Dimethyl-6-hydroJcy"-pyrimidine is soluble in hot benzene 
and uracil is not. Thus, potassium salt formation of the 
former would take place more readily than of the latter. 
b. In the anion of the potassium salt of 2, 4-dimethyl-6-
hydroxy-pyrimidine (XXXV), there _are electron r�leasing 
substituents, methyl groups, at the 2- and 4-positions. 
The methyl groups would increase the basic strength of 
the anion of the salt and increase the nucleophilic dis­
placement reaction. In the anion of the mono-potassium 
salt of uracil, there are no electron releasing methyl 
groups. 
The reason that the method of synthesizing O, O-diethyl, 0-(2, 4-di­
methyl-6-pyrimidyl) phosphate (�XXVI) could not be applied to the 
synthesis of 0, 0, 0,0-tetraethyl, O, O-pyrimidine-2,4-yl diphosphate · 
might be due to these differences. A reaction between the mono­
sodium salt of uracil (XXXVII) and diethyl phosphorochloridate in 
benzene has been attempted (39) with no product obtained. This seems 
to indicate that the second difference (b. )  is more important. 
XXXVII 
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In the .di-sodium salt of uracil ( XXVII), the anion on the 2-
carbon -is more basic and thus would be more readily attacked by the 
nucleophilic agent than the anion on the 4-carbon (Fig. 8). In this 
experiment, uracil was obtained as the product when treated with water. 
To explain this, the assumption was made that the monophosphorylated 
compound (XXVIII) was obtained but was not stable in the presence of 
water (Fig. 18). 
ON a 
N� 
� ( 1  . N  J EtO-�  
OEt 
XXVIII 
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I I  
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I 
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Fig. 18 Hydrolysis of sodium salt of 0, 0-diethyl, 0-( 4-hydroxy-
2-pyrimidyl) phosphate 
EXPERIMENTAL 
All melting points recorded in this work were taken using a 
capillary tube melting point apparatus ( Tottoli) and are uncorrected. 
To determine silver content, the silver compound was titrated with 
ammonium thiocyanate using ferric ammonium sulfate as the indicator . 
Nitrogen content was determined. by the Kjeldahl semi-micro method . 
PREPARATION OF URACIL ( 21) : 
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Thirty percent fuming sulfuric acid (1080 gm., 600 ml.) was 
diluted with 95 percent sulfuric acid (4o2 gm., 225 ml.) to make 15 
percent fuming sulfuric acid ( 1482 gm. , 825 ml.). In a 5000-ml., 
round-bottomed, three-necked flask fitted with an efficient mechanical 
stirrer and a thermometer was placed the 15 percent fuming sul-
furic acid (1304 gm. , 800 ml.) which was chilled to o0 in a freezing 
mixture. Into the flask, crystalline urea (200 gm. , 3. 20 mole) was 
added gradually with stirring at a rate .to keep the temperature 
below 10°. This step required one hour . Pulverized commercial malic 
acid (200 gm. , 1. 50 mole) was then added at once and the flask was 
fitt�d with a water-cooled condenser and heated on the steam-bath 
for one hour. During the first 15 minutes, large volumes of carbon 
monoxide, carbon dioxide and sulfur dioxide were evolved. At the end 
of the heating period, the flask was cooled and its contents were 
poured into ice water (2400 ml. ) .  On cooling , the crude uracil 
; / 
separated. The yield of the crude product was 123 - gm.. ( 65 . 3%). The 
uracil was washed with water ( suspended in wat·er and again filtered) 
and recrystallized from boiling water (2500 ml.) with the aid of 
charcoal (20 gm.) . After drying at 100° . for four hours, the recrys-. ' 
tallized product weighed 96. 4  gm. , which was 51 . 2  percent of the 
theoretical amount and melted at 333-335
° 
( reported : yield,· 50-55%, 
m.p. JJ5°) 
PREPARATION OF 2,4-DICHLOROPYRIMIDI�E '( 18. 40) : 
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, � mixture of uracil (25.0 gm., o.445 mole) ; phosphorus oxychloride 
(125 m1. ; 1.40 mole) and N, N-dimethylaniline (31 ml., 0.24 mole) was 
refluxed for two hours. The dark brown homogeneous solution was cooled 
and most of the excess phosphorus oJcyTchloride was distilled under 
reduced pressure. Crushed ice (180 gm.) was then gradually added to 
the dark-colored viscous residue with vigorous stirring. The temper- . 
0 ature of the mixtu-re was kept below 20 during this treatment because 
of the ease of hydrolysis of the dichloropyrimidine to uracil. After 
five minutes, ether (250 ml.) was added. The ether layer was washed 
with four 50-ml. portions of water and dried over anhydrous sodium 
sulfate. The ether was removed by distillation and the residue was 
· distilled under reduced pressure. The product, 2, 4-dichloropyrimidine, 
was collected as colorless crystals at 88°/17 mm. The yield of the 
· product was 23 gm. (7of,), m.p. 60-62
° ( reported: yield, 871,, m.p. 
61-62°, b.p. 100°/22 nnn.). 
PREPARATION OF SILVER DIETHYL PHOSPHATE ( 22, 23, 27, 41): 
In a 500-ml. , round-bottomed flask (with condenser), a mixture 
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of triethyl phosphate ( 90 gm. , o.49 mole) , barium hydroxide octa­
hydrate, and water (200 ml.) was refluxed for one and one-half; hours. 
The hot mixture was saturated with carbon dioxide, cooled and filtered. 
The filtrate was concentrated to a small volume and diluted with eth­
anol to give barium tetraethyl diphosphate. After filtering and drying, 
the crude product weighed 59.4 gm. (57.6%) . To obtain a pure product , 
the crude barium salt was dissolved in a minimum amount of hot water 
and hot ethanol (2000 ml.) was added. The water-ethanol solution was 
cooled slowly and the barium salt precipitated out in white, shining 
needle-form crystals. The yield of the recrystallized product , which 
does not melt over a flame, was 47 . 7  gm. (46 �3%). Twenty m.1.. of 50 
percent silver nitrate solution containing 10. gm. (0.060 mole) and 60 
ml. of 3.8 percent sodium hydroxide solution containing 2.3 gm. 
(0.060 mole) were prepared with carbon dioxide free water and mixed. 
The precipitate of silver oxide ( 6. 9  gm. , 9.060 mole) was washed with 
carbon dioxide free water by decantation. The recrystallized barium 
tetraethyl phosphate (13.2 gm., 0.0298 mole) was decomposed by the 
theoretical amount of sulfuric acid ( 58 . 30 ml. , 1.024 N, 0. 02900 mole) 
with stirring, care being taken to avoid an excess · of acid. After 
20 minutes, the suspension was filtered through a Buchner funnel 
which was precoated with a bed of Filteraid to remove the barium 
sulfate. The filtrate was neutralized by the freshly prepared silver 
oxide (6.9 gm., 0.060 mole) in the dark. The neutralized solution 
(pH 5) was evaporated in vacuo to give a white waxy product of silver 
diethyl phosphate which weighed 16. 0 gm. ( 100%) , m.p. 115-150°. The 
�ilver salt was recrystalliz·ed from purified dioxane and stored in 
the dark. The yield of the recrystallized product (white, shining, 
needle-form crystals) was 12. 0 gm. (75%), m.p. 150-155°. Silver 
content of the salt was 41. 08 percent (theoretical: 41. JJ percent) . 
ATTEMPTED PREPARATI0N ' 0F o.o,o,o-TETRAETHYL, 0,0-PYRIMIDINE-2, 
4-YL· DIPHOSPHATE (19) : 
A. Benzene as solvent: 
In the dark, 2 , 4-dichloropyrimidine ( J. O  gm. , 0. 020 mole) , 
freshly prepared silver diethyl phosphate (15.8 gm. , 0. 0605 mole) , 
anhydrous calcium sulfate (5.0 gm.) and benzene (60 ml. ) were placed 
in a 250-ml. , round-bottomed flask with condenser. The mixture was 
warmed at 50° for JO minutes and then heated to reflux for one and 
one-half hours. Vigorous stirring was ma'intained throughout. After 
cooling, the reaction mixture was suction-filtered through a B;;chner 
funnel. The benzene was removed from the filtrate by distillation 
on a water bath under water pump pressure. The resulting yellow 
syrup ( 1. 5  gm.) gave a positive test for silver ion and turned to 
bluish-purple on exposure to light. The pale yellow residue from the 
filtration, which also turned bluish-purple on exposure to light, was 
extracted with three 50-ml. portions of hot acetone and the extract 
was evaporated in vacuo to a small volume. 
28 
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Skelly B (-400 ml. ) was added to the syrup to induce - crystallization. 
No crystalline product was obtained except a trace amount of impurity. 
No product could be isolated . from the reaction mixture . 
B �  Dioxane as solvent : 
In an Ehrlenmeyer flask (�th condenser) . · silver di�thyl 
phosphate (1 gm., 0 .004 mole) and purified dioxane (100 ml . ) were 
·heated in the dark. After · the silver sa�t dissolved, 2, 4-dichloro-
pyrimi_dine (O .J gm. ; 0.002 mole) was added . The colorless dioxane 
· solution turned yellow with some black precipitate in a few minutes 
af't�r reflux started . The same result was obtained in about one hour 
if the temperature was kept around 60° . The fact that � .. in the absence 
of 2, 4-dichloropyrimidine, a dioxane solution of the silver salt 
changed from colorless to light red with a black precipitate after 
being heated at 60° for three hours led to the conclusion that the 
silver salt was not stable in purified dioxane and dioxane would not 
be useful as the solvent in this reaction-. 
C. Without any sol vent : 
A mixture of silver diethyl phosphate ( 1  gm., 0 .004 mole) and 
2, 4-dichloropyrimidine (O . J  gm . ,  0.002 mole) was heated at 135
° 
on a 
wax bath overnight . The soft solid was extracted with purified 
dioxa.ne (50 ml . ) and filtered. The solvent was removed from the 
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filtrate under reduced pressure and a small amount of yellow syrup was 
left. The syrup did not solidify on cooling and gave a negative test 
for silver ion. The same result was observed when the mixture was 
heated at 155° for six hours. The two different ways of heating were 
also applied to a mixture of silver diethyl phosphate (0. 5 gm. , 0.002 
mole) and 2, 4-dichloropyrimidine (0.3 gm. , 0.002 mole) . The same 
results were obtained. 
ATTEMPTED PREPARATION OF TETRASILVER ,·o, O-PYRIMIDINE-2, 4-YL 
DIPHOSPHATE (19, 24) : 
A .  B�nzene as solvent: 
In the dark, 145 ml. of normal hydrated trisodium orthophos-
phate solution containing 18. 0 gm. (0. 0421 mole) was poured into 150 ml. 
of normal silver nitrate solution containing 25 . 0  gm. (0. 148 mole) . 
The yellow precipitate of trisilver phosphate was collected by suction 
filtration, washed with water, dried in·the oven (105
°) to constant 
weight and stored in the dark. In a 250-ml., round-bottomed flask 
fitted with a water-cooled condenser, an efficient mechanical stirrer 
and an inlet tube for nitrogen were placed 2, 4-dichloropyrimidine 
( 2. 50 gm . , 0 . 0168 mole) , the freshly prepared silver phosphate (17. 0 
gm.,  0. 0410 mole) and benzene ( 50 ml.) .  The mixture was refluxed 
·with stirring in an atmosphere of nitrogen for 24 hours in the dark. 
After being cooled to room temperature, the mixture was filtered. 
The yellow residue was not soluble in water but soluble in ammonium 
hydroxide (silver phosphate?) .  The benzene was removed from the 
filtrate. The appearance and the melting point (57-61°) of the 
yellow solid residue, which weighed 2.6 gm. , indicated that the resi­
due was the starting material, 2, 4-dichloropyrimidine . 
B. Without any solvent: 
In the . dark, freshly prepared dry silver phosphate (17. 0  gm. , 
0.041 mole) and 2, 4-dichloropyrimidine ( 2. 5  gm. , 0. 0168 mole) were 
placed in a 50-ml., round-bottomed, two-necked flask fitted with an 
inlet tube for nitrogen , air-cooled condenser, and a gas outlet and 
heated at 120° in an atmosphere of nitrogen overnight. This method 
was not successful apparently because of the sublimation of the 
dichloropyrimidine onto the cooler upper area of the reaction appa­
ratus at this reaction temperature. 
ATTEMPTED PREPARATION OF TErRASODIUM�O,O-PYRIMIDINE-2,4-YL 
DIPHOSPHATE ( 19) : 
Trisodium orthophosphate duodecahydrate (35. 7505 gm.) was dried 
in the oven ( 105°) to constant weight (18. 7.545 gm. , i.e. 1. 592 moles 
water of hydration/mole). In a 100-ml. , round-bottomed flask fitted 
with condenser were placed the dried sodium phosphate (7 .10 gm. , 
0. 0353 mole) , 2, 4-dichloropyrimidine (2. 50 gm . ,  0. 0168 mole) and 
Jl 
redtstilled xylene ( 50 ml.). With stirring, �he mixture was heated 
to reflux for 12 hours. Aft�r cooling, the reaction mixture was 
filtered with suction. The 'residue ( 7. 5  gm.) gave a negative test 
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for chloride and was extracted with three 50-ml. portions of hot 
alcohol. The solvent was removed from the extract and only a trace 
amount of yellowish solid impurity was left. The xylene was distilled 
under reduced pressure from the_filtrate and the appearance and the 
melting point (56-62°) of the yellow solid residue, which weighed 
2_. 7 gm.,  indicated that the residue was the starting material, 2, 4-
dichloropyrimidine. 
ATTEMPTED PREPARATION OF 2,4-DIIOOOPYRIMIDINE: 
A. Acetone as solvent ( 28) : 
Sodium iodide was dried in the oven (110°) for two hours. A 
mixture of anhydrous sodium iodide ( 9.1 gm • •  0.064 mole) and 2, 4-di­
chloropyrimidine (1. 48 gm., 0.0100 mole) in redistilled acetone 
(200 ml.) was refluxed for 48 hours. Arter cooling , the reaction 
mixture with a trace amount of precipitate was filtered. The acetone 
solution was evaporated in vacuo and the residue was extracted with 
hot anhydrous benzene (100 ml.). The benzene extract was concentrated 
at reduced pressure. The product distilling at 85°/15 mm. was col­
lected and weighed 0. 5 gm. , m.p. 60-62° ( reported : 2, 4-dichloro­
pyrimidine melts at 61-62°) .  
JJ 
B. 2-Butanone as solvent (25, 42): 
A mixture of anhydrous sodium iodide (8. 0 gm. , 0. 054 mole) and 
2-butanone· ( 70 ml. ) was heated on a steam bath for one hour with a 
water-cooled reflux condenser. 2, 4-Dichloropyrimidine (2. 0 gm. , 0. 0lJ 
mole) was added to the mixture and heating was maintained for an addi­
tional 48 hours with occasional._shaking. The reaction mixture with 
a trace amount of precipitate was cooled to room temperature and 
filtered through a Buchner funnel with suction. The residue was 
washed. with 2-buta.none (15 ml. ) .  The butanone solution was evaporated 
in vacuo and the residue was extracted with hot benzene (100 ml.. ).  
The benzene extract was evaporated under reduced pressure and the 
product boiling at 87°/15 mm. was collected and weighed 0 . 5  gm. , m. p. 
60-62° (reported: 2, 4-dichloropyrimidine melts at 61-62°). 
ATTEMPTED PREPARATION OF 0,0-DIETHYL,0-( 2-HYDROXY-4-PYRIMIDYL) 
PHOSPHATE (20) : 
In a 100-ml. , round-bottomed, three-necked flask fitted with an 
efficient mechanical stirrer , a reflux condenser and inlet of nitrogen 
gas were placed uracil (11. 2 gm. , 0 . 100 mole) , potassium carbonate 
{14. o gm., 0. 100 mole) and benzene (25 ml. ) .  The mixture was refluxed 
for three hours with stirring and the small amount of water formed was 
removed by azeotropic distillation. Diethyl phosphorochloridate (19. 0 
gm. , 0.110 mole) was then added and the mixture was refluxed for eleven 
hours. The - suspension was allowed to cool to room -temperiture and 
filtered with suction. · The residue was washed with benzene. The 
filtrate ·and the washings were combined and washed with five percent 
potassium carbonate (20 ml.) and two 20-ml. portions of water and 
dried over sodium sulfate overnight. The syrup (3 gm.) obtained 
on solvent removal did not solidify on cooling. The filter cake was 
extracted with three 50-ml. po�tions of hot acetone, th�ee 50-ml. 
portions of hot chlorofo�, ancf three 50-ml. portions of hot dioxane. 
· Only trace amounts of impurity ( syrup) �th strong odor ( garlic-like) 
·were obtained after each solvent fraction was evaporated under reduced 
pressur�. The residue was also extracted with three 50-ml. portions 
ot hot alcohol and a trace amount of white crystals precipitated in 
the alcohol extract on cooling. A Kjeldahl determination indicated 
that these white crystals contained no nitrogen. No product could 
be isolated from the reaction mixture • 
. . ATTEMPTED PREPARATION OF O. 0-DIE'THYL, 0-( 4-HYDROXY-2-PYRil1IDYL 
PHOSPHATE (20, 42) : 
Uracil (11.2 gm. , 0.100 mole) was added to a solution of sodium 
hydroxide ( 187 ml . , 1. 07 N • 0. 200 mole) • After heating for one-
half hour, the solvent was evaporated under reduced pressure and the 
residue (disodium salt of uracil) was dried in the vacuum oven for 
four hours . The dried product weighed 17. 9 gm. (115% apparent yield) 
and did not melt over a flame. In a three-necked, round-bottomed flask 
fitted with an efficient mechanical stirrer and water-cooled condenser, 
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the disodium· salt of uracil ( 10.0 gm. , 0.0641 mole) , diethyl phos­
phorochloridate (11.1 gm. , 0.0641 mole), mercurous chloride ( 0. 300 gm., 
0.00110 mole) and benzene ( 100 ml.) were heated to reflux for 12 
hours. The reaction mixture was cooled and filtered. The dried 
re·sidue wa.s washed by suspending in water with stirring and then 
filtered. The insoluble residue (7 .9  gm. ) melted at 320-335° . This 
indicated that the residue was the starting material, uracil, with 
some impurity. 
/ 
-, 
RESULTS AND CONCLUSIONS 
According to the procedure of Davidson and Bandisch, uracil 
was synthesized in a yield of 51 percent ( reported yield: 50-55 
percent) ; following the method of Whittaker , 2, 4-dichloro-pyri� 
i 
midine was synthesized with a yield of 70 p�rcent ( reported yield: 
87 percent). Various methods w�re applied to the uracil and the 
dichloropyrimidine to test the feasibility of phosphate formation of 
�racil . All of the attempts were unsuccessful. 
The first synthetic route (Fig. 7) was planned according to 
the aliphatic property of 2 , 4-dichloropyrimidine and the negative 
results indicated that the chloro groups at the 2- and 4-positions 
of the dichloropyrimidine were not reactive enough toward nucleo­
philic substitution reactions in comparison with chloro groups in 
alkyl chlorides. The introduction of the fluoro group . a highly 
electronegative group. at the 5-position would withdraw electrons 
by an inductive mechanism and activate the substituents ·at the 2- and 
4-positions (44). By the activating effect of the fluoro group, the 
phosphate formation (XIV) from 2, 4-dichloro-5-fluoropyrimidine and 
the metal salt of dialkyl phosphoric acid may be possible. 
In the second synthetic route (Fig. 8) , uracil was used as the 
starting material. Although 5-fluorouracil is bio-isosteric to uracil, 
the introduction of a fluoro group at the 5-position has a great effect 
on the electron distribution in the molecule and thus , the acid 
strength of 5-fluorouracil is JO times that of uracil (2) . Although 
with the higher acidity, 5-fltiorouracil forms a potassium salt more 
readily than uracil, the fluoro group would delocalize the negative 
�barge on the o,cjTgen of the anion of the potassium salt (XXXVIII) and 
thus, would stabilize the anion and reduce its basic strength. 
XXXVIII 
Since the anion of the mono-potassium salt of uracil (XXII) appeared 
to be too weakly basic to react with diethyl phosphorochloridate, it 
seems �even less possible to synthesize O, O, O, O-tetraethyl, 0,0-(5-
fluoropyrimidine-2, 4-yl) diphosphate (XIV) by this method. 
J? 
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